CD2 is a bit of a sleeper. As the US emerges from COVID-19 asset values of small to medium private companies will grow strongly.
Maybe time to top up and take advantage of the NTA to unit price gap.
CD2 is a bit of a sleeper. As the US emerges from COVID-19 asset...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CD2 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.23M | |||
| Open | High | Low | Value | Volume |
| 90.0¢ | 90.0¢ | 90.0¢ | $4.045K | 4.494K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 93.0¢ | 7061 | 2 |
View Market Depth
| Last trade - 10.05am 30/08/2024 (20 minute delay) ? |
| CD2 (ASX) Chart |